187 related articles for article (PubMed ID: 36291173)
1. Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect.
Fithroni AB; Kobayashi K; Uji H; Ishimoto M; Akehi M; Ohtsuki T; Matsuura E
Cells; 2022 Oct; 11(20):. PubMed ID: 36291173
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
Takeuchi I; Nomura K; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
4. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
[TBL] [Abstract][Full Text] [Related]
5. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
6. Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy.
Chen J; Yang Q; Liu M; Lin M; Wang T; Zhang Z; Zhong X; Guo N; Lu Y; Xu J; Wang C; Han M; Wei Q
Int J Nanomedicine; 2019; 14():8161-8177. PubMed ID: 31632025
[TBL] [Abstract][Full Text] [Related]
7. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy.
Kimura S; Masunaga S; Harada T; Kawamura Y; Ueda S; Okuda K; Nagasawa H
Bioorg Med Chem; 2011 Mar; 19(5):1721-8. PubMed ID: 21315608
[TBL] [Abstract][Full Text] [Related]
9. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
10. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
Kawasaki R; Sasaki Y; Akiyoshi K
Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: A potential boron agent with enhanced selectivity of tumor cellular uptake.
Quan H; Fan L; Huang Y; Xia X; He Y; Liu S; Yu J
Colloids Surf B Biointerfaces; 2021 Aug; 204():111826. PubMed ID: 33984611
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
[TBL] [Abstract][Full Text] [Related]
14. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Boron Uptake in Brain Glioma by a Boron-Polymer/Microbubble Complex with Focused Ultrasound.
Fan CH; Wang TW; Hsieh YK; Wang CF; Gao Z; Kim A; Nagasaki Y; Yeh CK
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11144-11156. PubMed ID: 30883079
[TBL] [Abstract][Full Text] [Related]
16. Water-soluble BODIPY-nido-carborane nanoparticles applied to biocompatibility tumor cell imaging.
Dai D; Lian G; He X; Feng J; Jin G
Photochem Photobiol Sci; 2022 Feb; 21(2):185-194. PubMed ID: 35061200
[TBL] [Abstract][Full Text] [Related]
17. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer.
Sumitani S; Oishi M; Yaguchi T; Murotani H; Horiguchi Y; Suzuki M; Ono K; Yanagie H; Nagasaki Y
Biomaterials; 2012 May; 33(13):3568-77. PubMed ID: 22326646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
